News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
127 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25546)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
3 (175)
4 (194)
5 (187)
6 (176)
7 (131)
10 (121)
11 (134)
12 (155)
13 (130)
14 (129)
17 (127)
18 (156)
19 (119)
20 (149)
21 (120)
24 (139)
25 (164)
26 (151)
27 (149)
28 (90)
30 (3)
31 (150)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
30
31
Drug Development
Repros Therapeutics Inc. Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis
March 17, 2014
·
1 min read
Bio NC
Argos Therapeutics, Inc. To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
March 17, 2014
·
1 min read
Business
Agilent Technologies Inc. To Support National University of Singapore (NUS) Research Consortium To Identify, Map Lipid Levels In Healthy People
March 17, 2014
·
1 min read
Business
Ligand Pharmaceuticals Inc. Earns $1 Million Milestone Payment Triggered By FDA Approval Of FDA’s NOXAFIL® (Posaconazole) Injection For Intravenous Use, A New Captisol-Enabled Formulation
March 17, 2014
·
1 min read
Drug Development
Ocular Therapeutix, Inc. Begins Phase 3 Clinical Trial For Its Sustained Release Dexamethasone
March 17, 2014
·
1 min read
Pharm Country
Rheonix, Inc. Further Expands Intellectual Property Portfolio With Six Patents For Its Microfluidic Systems
March 17, 2014
·
2 min read
Genetown
ImmunoGen, Inc. Announces Presentations By Company Scientists At Upcoming American Association for Cancer Research Annual Meeting
March 17, 2014
·
1 min read
New VolitionRX Study Data Demonstrates Nuq® Assays’ High Detection Rate Of Prostate Cancer And The Ability To Distinguish Between Prostate And Colorectal Cancer
March 17, 2014
·
4 min read
Drug Development
Amgen’s Talimogene Shines In Phase 3 Melanoma Trial
March 17, 2014
·
9 min read
Policy
Unveiled Emails Raise Eyebrows About Johnson & Johnson’s Ties To Consulting Docs
March 17, 2014
·
1 min read
Previous
10 of 13
Next